Clinical Trials Directory

Trials / Completed

CompletedNCT03951090

Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.

Detailed description

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (\> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results. This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Conditions

Interventions

TypeNameDescription
OTHERResults of the brief geriatric assessmentProviders will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
OTHERNo results of brief geriatric assessmentsProviders will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment

Timeline

Start date
2016-04-25
Primary completion
2018-04-24
Completion
2018-04-24
First posted
2019-05-15
Last updated
2019-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03951090. Inclusion in this directory is not an endorsement.